Filing Details
Oncology Institute, Inc. (NASDAQ:TOI) filed a Form 8-K with the Securities and Exchange Commission on August 03, 2026, disclosing a material event.
8k filedNASDAQ:TOI
Oncology Institute, Inc. (TOI) Reports Material Event to SEC
Filing Details Oncology Institute, Inc. (NASDAQ:TOI) filed a Form 8-K with the Securities and Exchange Commission on August 03, 2026, disclosing a material event. Market Context…
Market Context
Oncology Institute, Inc.'s stock currently trades at $5.13 with a market capitalization of $370.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Oncology Institute, Inc.'s stock.
All SEC filings for Oncology Institute, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TOI Stock Page
Frequently Asked Questions
Where can I read TOI's SEC filings?
Browse all filings on our TOI SEC filings page.
What types of SEC filings does Oncology Institute, Inc. file?
Public companies like Oncology Institute, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.